Skip to main content

Table 2 Clinical characteristics and outcome after triple antibiotic therapy

From: Clinical pilot study: efficacy of triple antibiotic therapy in Blastocystis positive irritable bowel syndrome patients

Patient Age yrs Duration of symptoms (years) Previous AB therapy Blastocystisload in baseline faeces BlastocystisST’s SerumIgA g/L Diary score Clinical score?>?=1 point Clearance at 6 weeks
1 35 4 Yes (F,O) 2+ 3,4,6 1.51 +4.1 Yes Yes
2 59 5 No 2+ 7 1.12 (L) +2.4 Yes No
3 28 1.5 Yes (F) 1+ 1 2.1 ?0.3 No No
4 35 0.25 Yes (F,O) 1+ 3 2.2 +0.2 No Yes
5 51 1.5 Yes (F) 1+ 3,4,6 2.82 +2.0 Yes No
6 58 0.5 No 2+ 1,4 1.03 (L) +1.1 Yes Yes
7 73 0.75 No 1+ 3,4 1.22 +4.5 Yes Yes
8 49 10 Yes (F,O) 3+ 8 1.94 +1.3 Yes No
9 63 1 No 1+ 3 0.75 (L) ?0.8 No Yes
10 36 1 Yes (F) 2+ 3 0.98 (L) ?0.6 No Yes
  1. F = Flagyl.
  2. O = other antibiotics (metronidazole, nitazoxanide, norfloxacillin).
  3. L = low, <1.24 g/L, level defined by laboratory.